皮肤病用cAMP磷酸二酯酶-IV抑制剂的化学、生化与结构异同
本文比较了已获批皮肤科应用的三种PDE4抑制剂:罗氟司特(外用,用于银屑病、脂溢性皮炎和特应性皮炎)、阿普米司特(口服,用于银屑病)和克立硼罗(外用,用于特应性皮炎)。文章还分析了PDE4抑制剂的理化原理,并通过磷酸二酯酶催化域序列比对发现许多未报道的不变残基,这些残基结合1个Zn和1个Mg离子及5个结构水分子。
要点
- 三种PDE4抑制剂适应症不同:罗氟司特外用治疗银屑病、脂溢性皮炎和特应性皮炎。
- PDE4抑制通过延长cAMP信号 duration 和增加细胞内cAMP浓度产生抗炎作用。
核心结论
- PDE4抑制剂通过延长cAMP信号和增加细胞内cAMP浓度发挥抗炎作用。
- 磷酸二酯酶催化域序列比对发现许多未报道的不变残基,参与结合Zn、Mg离子和结构水分子。
研究设计与样本
- 本文为综述/生化结构分析,未报告系统检索范围或样本量。
主要发现
- PDE4由至少4种外显子剪接异构体亚型组成,主要在免疫细胞中表达。
- 磷酸二酯酶催化域的不变残基结合1个Zn和1个Mg离子及5个结构水分子,用于定向攻击性μ-羟基/μ-氧负离子并稳定2个非桥连磷酸氧原子。
- 磷酸二酯酶中二价金属离子的排列与经典磷酸基转移机制无关。
关键数值与推荐
- 罗氟司特适应症:外用治疗银屑病、脂溢性皮炎和特应性皮炎。
- 阿普米司特适应症:口服治疗银屑病。
- 克立硼罗适应症:外用治疗特应性皮炎。
临床怎么用
- 临床选择PDE4抑制剂时需考虑适应症差异:罗氟司特外用可用于银屑病、脂溢性皮炎和特应性皮炎,阿普米司特口服用于银屑病,克立硼罗外用用于特应性皮炎。
- 罗氟司特体外抑制效力最强,但需结合临床疗效和安全性综合评估。
局限性
- 本文为综述/结构分析,未报告临床疗效或安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Roflumilast, the third phosphodiesterase-IV (PDE4) inhibitor approved for use in dermatology, is indicated for topical treatment of psoriasis, seborrheic dermatitis, and atopic dermatitis, whereas its 2 predecessors, apremilast and crisaborole, are indicated for oral treatment of psoriasis and topical treatment of atopic dermatitis, respectively. All 3 are rationally designed PDE4 inhibitors, but roflumilast is the most potent and effective among the 3, with in vitro inhibitory constant half-maximal inhibitory concentration value of 0.7 nM (roflumilast), 0.14 μM (apremilast), and 0.24 μM (crisaborole), representing differences of over 3 orders of magnitude. PDE4 is a cAMP (an intracellular secondary messenger) hydrolase consisting of at least 4 subtypes of exon-spliced isoforms, which are primarily expressed in immune cells for inflammatory response. PDE4 inhibition lengthens the duration of cAMP signals and increases cellular cAMP concentrations, generating anti-inflammatory effects. We examined the physicochemical principles that make PDE4 inhibitors effective and propose chemical modifications to improve them. Sequence alignment of the catalytic domains of all phosphodiesterases identified many previously unreported invariant residues. These residues bind 1 Zn and 1 Mg ion plus 5 structural water molecules for orienting an attacking μ-hydroxyl/μ-oxo anion and for stabilizing 2 nonbridging phosphate oxygen atoms. The arrangement of the 2 divalent metal ions in phosphodiesterases is not related to that of the classic mechanism for general phosphoryl transfer.
引用
- Wang J, Ho M, Bunick CG, et al. Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors. J Invest Dermatol. 2024. PMID: 39608668. doi:10.1016/j.jid.2024.10.597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。